Canada markets close in 31 minutes

Plantable Health Inc. (PLBL.NE)

NEO - NEO Real Time Price. Currency in CAD
Add to watchlist
0.02000.0000 (0.00%)
As of 02:30PM EDT. Market open.
Full screen
Previous Close0.0200
Open0.0250
Bid0.0150 x N/A
Ask0.0200 x N/A
Day's Range0.0150 - 0.0250
52 Week Range0.0100 - 0.4400
Volume77,681
Avg. Volume52,153
Market Cap1.265M
Beta (5Y Monthly)N/A
PE Ratio (TTM)N/A
EPS (TTM)-0.1260
Earnings DateN/A
Forward Dividend & YieldN/A (N/A)
Ex-Dividend DateN/A
1y Target EstN/A
  • Newsfile

    Plantable Health Announces Preliminary Results from Its Myeloma Cancer Trial

    New York, New York--(Newsfile Corp. - October 4, 2022) - Plantable® Health Inc. (NEO: PLBL) (OTCQB: PLBLF) ("Plantable" or the "Company") today announces preliminary results from its Myeloma Cancer Trial, NUTRIVENTION clinical trial (NCT04920084), that were presented at the 19th International Myeloma Society Annual Meeting, showing the Company as a potential intervention in empowering patients with diet-related chronic conditions."We're very pleased to share these preliminary results. Nearly hal

  • Newsfile

    Plantable Health Provides a Solution for Healthcare Plans Seeking Savings in Chronic Conditions with the RebootRX

    New York, New York--(Newsfile Corp. - September 29, 2022) - Plantable® Health Inc. (NEO: PLBL) (OTCQB: PLBLF) ("Plantable" or the "Company") announced its plans to expand the Company's reach into the self-funded marketplace with the launch of the RebootRx. Proven on the individual level, Plantable's RebootRx product will offer self-funded employers a value-based solution to reverse chronic disease with high levels of adherence and engagement, leading to better outcomes both for the individual's

  • Newsfile

    Plantable Health Inc. Reports Second Quarter Financial Results

    New York, New York--(Newsfile Corp. - August 9, 2022) - Plantable Health Inc. (NEO: PLBL) (OTCQB: PLBLF) ("Plantable" or the "Company"), a clinically supported dietary intervention program to reverse and prevent chronic disease, today reported the Company's financial results for the second quarter ended June 30, 2022."When we founded Plantable, the concept of having a turnkey solution that reversed diet-related chronic disease, paid for by the insurer, was novel. We were very early," said ...